Post by stcks on Apr 27, 2018 23:05:45 GMT
Summary
Biotechnology is one of the sectors with the greatest potential for growth in the coming years.
Investing in new breakthroughs like gene therapy, cancer-killing T-cells, treatment for depression, diabetes or Alzheimer's disease can be very lucrative.
Merger mania has struck the biotech industry when major pharmaceutical companies are seeking to boost their future growth rate.
The SPDR S&P Biotech EFT provides exposure to early-stage biotech companies focusing on rare diseases and cutting-edge therapies.
Chinese investors are pumping money into U.S. drug startups, so groundbreaking biotech firms are being flooded with cash.
seekingalpha.com/amp/article/4167100-xbi-invest-top-trending-sector
Biotechnology is one of the sectors with the greatest potential for growth in the coming years.
Investing in new breakthroughs like gene therapy, cancer-killing T-cells, treatment for depression, diabetes or Alzheimer's disease can be very lucrative.
Merger mania has struck the biotech industry when major pharmaceutical companies are seeking to boost their future growth rate.
The SPDR S&P Biotech EFT provides exposure to early-stage biotech companies focusing on rare diseases and cutting-edge therapies.
Chinese investors are pumping money into U.S. drug startups, so groundbreaking biotech firms are being flooded with cash.
seekingalpha.com/amp/article/4167100-xbi-invest-top-trending-sector
